Inotropic therapy for heart failure: An evidence-based approach
- 1 September 2001
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 142 (3) , 393-401
- https://doi.org/10.1067/mhj.2001.117606
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inotropes in the beta-blocker eraClinical Cardiology, 2000
- Parenteral inotropic support for advancedcongestive heart failureProgress in Cardiovascular Diseases, 1998
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Prognostic Significance of Plasma Norepinephrine in Patients With Asymptomatic Left Ventricular DysfunctionCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.Circulation, 1991
- Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 1990
- Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac MuscleJournal of Cardiovascular Pharmacology, 1989
- Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.Circulation, 1984
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984